CLGN
Collplant Biotechnologies Ltd
Mentions (24Hr)
0.00% Today
Reddit Posts
Positions you should start TODAY for 2027
Here’s why CLGN jumped yesterday, and why I’m buying more today
CLGN - Runnnnnnnning on the news they are converting to a LPU (laser PU)
LIVE: CEI, AVCT, MBOT, PYR, FTFT, CLGN, SPRB, RELI & Other Stocks. Where...
CLGN stock gone up by 35% - nothing major to be found in the news
Mentions
Thanks for appreciating! To put it shortly there are all kinds of differences, I believe CLGN (LightSolver) is the only one building an actual computer, meaning using the light to compute. There are a few photonic companies but they are doing different things. The CLGN edge is the use case and capabilities.
Thank you for sharing this. With regards to CLGN, are they in direct competition with other photonics company like POET etc.? What will be their edge against them?
First and foremost: experience. Claude not being able to recognize CLGN being used as a shell because of how the whole thing was announced is a classic example. Also the warrants are milestone based, so you could do very well on your investment way before those hit the market. Those warrants getting exercised will mean we made a lot of money. As for DRTS, thinking that becoming the standard of care for rGBM is priced in is lacking basic understanding of both what DRTS is and what the rGBM market is. And the LFWD turnaround as well, you got follow closely to pick up on what’s truly important before the market gives credit for it. If you want we could set some measurable targets, be it DRTS getting approved for cSCC, CLGN eventually changing its ticker, for LFWD I’m not sure what we could measure, maybe just sales? Or we could just follow the price in the coming months. Of course I could be wrong, and stuff could happen (or not happen), but the way I research is longer and deeper than what AI could do with a simple prompt.
Ran it through Claude: >DRTS (Alpha Tau): FDA approval is not a “done deal.” The pivotal ReSTART results haven’t come out yet and are guided for late 2026 or early 2027. The Japan approval is real. At about $1.33B with no revenue, the stock already prices in a lot of success after a 275% run. >CLGN (CollPlant): LightSolver did not take over CollPlant. CollPlant bought LightSolver. The “1,000x faster than NVIDIA” figure is a 2023 company claim measured against a deep-learning solver, not a named NVIDIA GPU. The newer, bigger speedups come from an emulator, not real hardware. CollPlant has a going-concern warning and a commercial launch targeted for 2028. If milestones are hit and shareholders approve, up to 22.2M milestone-warrant shares could be issued against about 2M shares today. >OBIO (Orchestra BioMed): The post’s facts are the most accurate of the four. The $500–$1,600 per device is real but conditional. “A million units” is the company’s estimate of eligible patients worldwide, not a sales forecast. Most of the value depends on one double-blind trial readout in Q2 2027, and cash lasts into Q4 2027. >LFWD (Lifeward): The reimbursement claim dates from April 2024, under the previous CEO. H1 2026 revenue fell 2%. The share count rose about 86% in six months, with another 7.26M shares registered for resale. >Bottom line by ticker: DRTS has real clinical progress but most of the upside is already priced in, and the binary risk sits in the next 3–6 months. OBIO is a cleanly structured binary bet backed by Medtronic. CLGN is a speculative option on pre-commercial photonic hardware with a milestone-warrant overhang roughly 10x its share count. LFWD's turnaround isn't visible in the numbers yet.
It’s the same in a way that they are both gaming the market for a lack of better term, but with CLGN there will be nothing left of the old company, it will be all LightSolver and if I had to guess the ticker will change at some point to reflect that.
So, CLGN today is basically what is currently happening to GPRO?
Im in DRTS and CLGN. May return to LFWD. With a broad view the DRTS chart is fantastic although could use a bounce given very recent behavior. CLGN has a gradual overall lift since the $2.637 bottom late August (now at $3.98. LFWD’s chart is not encouraging but volume is very low (<10k generally). OBIO had an interesting bounce off the 50day yesterday (October 12). Need to look at it more. Thanks for the post
I may have complicated it. It’s very simple: CLGN = LightSolver. And I believe LightSolver is worth looking into (and investing in).
What do you mean by technical base? As in technical analysis of the chart? If so I agree, the market has yet to understand that CLGN is really just LightSolver now, and prior to that everything is irrelevant.
Sounds like a plan! Well three of the stocks I listed are medical, but CLGN is actually a very good solution for energy while also potentially having demand by your second sector of interest.
CLGN Don’t let the stock history fool you, it’s a whole new story and the chart should start in September when LightSolver used the ticker to go public at $3.40 Those who understand this will win big
Keep an eye on CLGN. Had a nice move today but it can go far, far higher.
I told you guys about QSI and it ran. I told you about CLGN and today it ran. I’m not posting bags. Waiting to post on AIRJ and RZLV. Not yet.
QSI made a big move and I think it happens again. CLGN took a dip and won’t stay down long. AIRJ drops so far that it meets this subs criteria. Sometime this quarter, they will update on commercialization. (Carrier for HVAC, GEV for AI data centers can’t both be wrong…) I had to exit RZLV which means it will probably run now. Don’t care. Don’t trust the management.
I'm very close to going full port on QSI and CLGN. CLGN is no longer a biotech. They're creating a new type of computer called a LPU because it uses lasers to do room temperature, speed of light calculations that typically take days and days for CPU/GPU clusters. It's not Quantum but it gets us far down the road on larger mathematical equations (e.g. calculating optimal routes for massive fleet deployments or calculating corrosion damage on airplane parts.) QSI announced yesterday that they have now effectively sequenced 19 of 20 amino acids. This is a game changer for biology and medicine. The precision at 19 makes the 20th almost a non-issue but they're convinced they'll hit 20 before EOY. Full commercialization to start Q1 2027. I'll hold onto my SPCX and AMD but I'm not expecting massive upside from here for a while. The market right now is getting narrower and narrower and more narrow. That's not a good sign. When I was younger, I lived in San Diego and we would either go into Tijuana or there were top quality Mexican Tequila houses in SanD itself. One of these places had a wide assortment of Mezcals, which are like Tequilas but they use Peyote cactus rather than Agave cactus. The problem is that Peyote can be converted into a hallucigenic. Anyway, my point is that I was having one or three too many shots of the Mezcal and that violates the second rule of Mezcal. The first rule of Mezcal is don't drink Mezcal. The second rule is that if you ignore the first rule, you must respect the Mezcal. My lack of respect manifested itself in the form of a "narrowing of vision." At first, I could see all around me like a normal, sober individual. Then, my vision narrowed. Eventually, I was looking through a vertical slit - not horizontal like I was squinting but more like a fetus moving through the birth canal trying to determine whether to pass through into the flourescent lights of the delivery room. And then I blacked out entirely. It was two (three?) days later that I remembered what I was doing at the mezcal bar and it wasn't a proud moment. They had the Reverend Al Green on the Karaoke and I decided to perform it as if I were Jim Morrison. The only saving grace was that most of my friends that were in attendance that evening pretended that they didn't know me (ever again) so that I don't have to re-live the horror of that night (although to be fair, most of them probably didn't remember a thing about it either. Such is Mezcal.). Anyway, the reason I bring this up is because the market appears to be saturated on Mezcal. Biotech was hot but it's rate sensitive and now the money doesn't flow there any more. I remember when software had a one week boost and now that's over. Semis and memory and storage and even space have all had their day in the sun and yet I can't help feeling that the overwhelming majority of the breadth of the market is in a descending bear market and it's only a matter of time before the bulls lose consciousness. Fear not. We will wake up a few days later and we will look at things like Wendy's, Nike as a value play, Hertz for a short squeeze and most of the meme stocks as if they were a bad memory of standing on a dining table, drunk on mezcal belting out "Take Me to the River." We will be ashamed but we will move forward and market breadth will return.
I like CLGN under $5.
CLGN has potential now they've taken over Lightsolver, also hoping for good things from COPR.
I’m going hard into CLGN. They’re no longer a biotech stock since they backed in LightSolver. The whole thing is still priced like a broken breast implant manufacturer that lost its largest customer. The AI bot I use got scared of the warrants but they’re all incentive based. If those incentives hit, the rerate comes in fast off a minuscule float. I’m not pumping. This thing has some challenges and some hair on it. But I can live with it if it has multi-bagger potential. DYOR.
Honestly it's a bit different, but very much reminds me of Blackberry. Been very big there since 2020, only now is it starting to complete the whole smartphone to security transformation, and I will be big one day. Hopefully $CLGN can do the same
Why would you say that? I would think at this point my account would be validated enough… I write everything myself, as a human, and only what I truly believe in and with real explanations. Have you read the post? Have you had a look at LightSolver? At CLGN?
I mean ok, but did you check LightSolver out? Did you understand the immense hidden value of the CLGN stock?
You are strengthening my case, the previous company is becoming irrelevant, it’s essentially like LightSolver did an IPO but used CLGN as the publicly traded vehicle to enter the market with.
It just became public a few trading days ago, first addressed investors just yesterday, and still has the cloud of the previous company all over it. I can’t wait for the name and ticker to change, that’s when people will start picking up on it. Although I ain’t waiting until then to load up! Best of luck with your research, and if we ever get a LightSolver (CLGN) TA post from you that be amazing.
Interesting. Feels like CLGN is still flying under the radar and most people haven’t connected the dots yet. Added it to my watchlist, gonna do some more research and probably pick up shares.
I’m watching RZLV holding this floor and the revenue numbers are too high to stay here. The Meta Muse AI will prove to be a catalyst since it kicks off agentic e-commerce and Rezolve is already positioned on the merchant side. I’m watching CLGN here and it, too, is holding this floor price. The CEO of LightSolver (effectively CEO of CLGN now) comes out tomorrow and lays out both the commercial and technical realities. We need to hear Boeing and one other customer (a major bank?) for the validation and path to financial nirvana. From the technical side, we need to hear full commercial viability in 2028. Give those two and the stock will start to rerate towards a far more reasonable $1.5B to $3B market cap.
forget it i'll give you one secret pick (CLGN)
CLGN RZLV Patience
Took a small gamble on CLGN for tomorrow. They're doing a 1-10 reverse split tonight and also announced their acquisition of LightSolver completed today which adds photonic computing and Laser Processing Unit technology alongside their regenerative medicine business. Not sure how it will play out so went in small with 250 shares, 25 after split. Will open with a 2.2M float and looks like most of the warrant dilution from the acquisition is phased in through technical/commercial milestones so it will not immediately affect the float.
CLGN hits the 10 - 1 reverse split tomorrow and from there, it’s all LightSolver. LightSolver may have something but they ain’t got no revenue. And won’t for a year. So I take a speculative position and pour more hard earned money into the hole called RZLV. Which better do something quick because the shorts are suffocating me and my RZLVW warrants.
CLGN popped up on my scanner
CLGN..Anyone have this stock? They have earnings Wednesday and they look promising. Just bought some.
Hey /u/Normal_Humor2399 - I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: IMMR CLGN NCNA. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.
Hey /u/Normal_Humor2399 - I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: IMMR CLGN NCNA. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.
I agree, their data is two weeks behind. You can find these stocks on your own by noting runners of the day then checking to see if they make it onto the reg sho threshold list a few days later. Then keep checking their CTB, even if they aren't on the threshold list. They should be ready for a second run 21 days after the first if CTB is high. This is about the cycle of the FINRA release, if timing is right, one can really hit the ground running. Next fully revised fintel should be evening of 1/11. My bet is that PYR, CLGN, DARE, CALT, RCAT, WEJO are all in the top 20 based on this method. Not financial advice, key word is "bet." This is a casino.
I've got SYTA, I'm with you. You might also want to look at PYR, RDBX, CLGN (all on reg sho threshold list). I'm looking forward to the updated FINRA on 1/11 to see what the real numbers are. I already bought PYR, up 10% today.
I strongly suspect that when the FINRA short report comes out on 1/11 that PYR, DARE, CLGN and RCAT will show as highly shorted. I like these stocks. They all had great news recently and current prices don't reflect the added value. Two are on the REG SHO threshold list. Not financial advice.
Matterport Sea Limited Gingko Bioworks AirBnb CLGN All working on interesting products - some more mature than others.
CLGN is a very interesting play on organ growing.
Thry are public but small CLGN
anyone know whats the deal with CLGN ?
CLGN - betting on fake boobies. Anyone looked into this? They’re commercializing regenerative aesthetic tissue (fake boobies) to make your wife’s boyfriend happy
CollPlant Biotechnologies $CLGN looks interesting. They released financials this morning. Revenues increased by 165% from $2.3 million to $6.1 million. They make collagen based breast implants. Thoughts?
I think cosmetic stuff has great potential. I own CLGN (working on better dermal fillers and breast implants) but will be looking into EOLS too.
Of you like boobs, then check out Collplant (CLGN). They are working on breast implants that could be as good as the real thing. That's part of why I bought shares in it - to invest in boobs!
Yeah, that's how it is for CLGN, MCBC, and MBWM for me. All under 1B but not penny stocks either and they have actual business operations so not many places they can be discussed. Share price shouldn't matter. You could have a 5M market cap with only 5000 shares outstanding, for example.
$CLGN-Today's filing reveals that Q1 of 2021 alone already has at least 14 million in revenue booked, as opposed to 6 million in 2020. It seems that 2021 will be a year in which CLGN actually turns a profit and will be their best year to date. Keep in mind the 14 million is only a partial payment from Allergan and CLGN is entitled to receive up to an additional $89 million in milestone payments. I belive this is what gave recent investors the confidence to invest at 17.50/share for a total invenstment of 35 million dollars. Just under 7 million shares in the float.
Shout out to CLGN coming off the offering super strong
Is this a decent place to ask what you guys think of this stock? CLGN (collplant) All of my knowledge on that company comes from webull. Their financials, their description, institutional holdings, all from webull. I havent seen this on any youtube videos or subreddits yet. I like the stock because it looks like they grew organically based on their charts. Not a stock that jumped up out of nowhere. Couple that with the fact they're an Israeli company, they're a biotech company, the stuff they're doing is not too insane so it seems easier to make money from and pitch to people in medicine, and they did a direct offering. Direct offerings are offerings directly to big investors which shows someone with huge teams of researchers thinks this company has upside potential at a price point of 17.50. Anything around that price should be a good bet with a little time. They were trading up to 24 right before the offering as well which in most cases means they'll be trading at or above that relatively soon.